ArticleCNS drugs2021

Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.

Emma Morton et al.PubMed ↗Publisher ↗

No numbers read from the abstract.